Immunosenescence and Immunogenetics of Human Longevity (original) (raw)

Skip Nav Destination

Article navigation

Issue Cover

Review Articles| November 26 2008

R. Ostan;

aDepartment of Experimental Pathology and Oncology, University of Florence, Florence,

Search for other works by this author on:

L. Bucci;

bDepartment of Experimental Pathology and

Search for other works by this author on:

M. Capri;

bDepartment of Experimental Pathology and

cCIG – Interdepartmental Center L. Galvani, University of Bologna, Bologna, Italy

Search for other works by this author on:

S. Salvioli;

bDepartment of Experimental Pathology and

cCIG – Interdepartmental Center L. Galvani, University of Bologna, Bologna, Italy

Search for other works by this author on:

M. Scurti;

cCIG – Interdepartmental Center L. Galvani, University of Bologna, Bologna, Italy

Search for other works by this author on:

E. Pini;

cCIG – Interdepartmental Center L. Galvani, University of Bologna, Bologna, Italy

Search for other works by this author on:

D. Monti;

aDepartment of Experimental Pathology and Oncology, University of Florence, Florence,

Search for other works by this author on:

C. Franceschi

bDepartment of Experimental Pathology and

cCIG – Interdepartmental Center L. Galvani, University of Bologna, Bologna, Italy

Search for other works by this author on:

Neuroimmunomodulation (2008) 15 (4-6): 224–240.

Content Tools

Abstract

At present, individuals can live up to 80–120 years, a time much longer than that of our ancestors, as a consequence of the improvements in life conditions and medical care. Thus, the human immune system has to cope with a lifelong and evolutionarily unpredicted exposure to a variety of antigens, which are at the basis of profound age-related changes globally indicated as immunosenescence, a multifaceted phenomenon that increases morbidity and mortality due to infections and age-related pathologies. The major changes occurring during immunosenescence are the result of the accumulation of cellular, molecular defects and involutive phenomena (such as thymic involution) occurring concomitantly to a hyperstimulation of both innate and adaptive immunity (accumulation of expanded clones of memory and effector T cells, shrinkage of the T cell receptor repertoire, progressive activation of macrophages), and resulting in a low-grade, chronic state of inflammation defined as inflammaging. It is unknown whether inflammaging, which represents a risk factor for most age-related pathologies, is a cause or rather an effect of the aging process. In this complex scenario, the role of genetic background likely represents a fundamental variable to attain successful aging and longevity. Accordingly, centenarians seem to be equipped with gene variants that allow them to optimize the balance between pro- and anti-inflammatory molecules, and thus to minimize the effects of the lifelong exposure to environmental insults and stressors. The remarkable features of the genetics of aging and longevity are reviewed, stressing the unexpected and unusual results obtained regarding such a postreproductive type of genetics.

This content is only available via PDF.

© 2008 S. Karger AG, Basel

2008

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.

Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.

Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

You do not currently have access to this content.

Sign in

Digital Version

Pay-Per-View Access

$39.00

1 Karger Article Bundle Token

$150

Rental

This article is also available for rental through DeepDyve.